Covid-19 roundup: Sanofi promis­es to bring re­com­bi­nant vac­cine ca­pac­i­ty to 1B+ while scal­ing up mR­NA man­u­fac­tur­ing

Sanofi be­lieves it’s lined up two of the best shots at a Covid-19 vac­cine by team­ing up with Glax­o­SmithK­line on the old­er re­com­bi­nant ap­proach and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.